Position statement on the use of albumin in liver cirrhosis Graciela Castro-Narro; Carlos Moctezuma-Velázquez; Rene Male-Velázquez; Rafael Trejo-Estrada; Francisco Javier Bosques; Rosalba Moreno-Alcántar; Heriberto Rodríguez-Hernández; Aleida Bautista-Santos; Carlos Córtez-Hernández; Eira Cerda-Reyes; Juanita Pérez-Escobar; Juan Manuel Aldana-Ledesma; Jonathan Aguirre-Valadez; José Antonio Velarde Ruiz-Velasco; Raúl Contreras-Omaña; Godolfino Miranda-Zazueta; Monica del Rocío Reyes-Bastidas; Javier Manuel Meza-Cardona; Norberto Chávez-Tapia; Nicolas Joaquín Fernández-Pérez; Edgar Santino García-Jiménez; Aldo Torre;

Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany Wolfgang Maximilian Kremer; Simon Johannes Gairing; Leonard Kaps; Esmeralda Ismail; Vasiliki Kalampoka; Max Hilscher; Maurice Michel; Ekkehard Siegel; Jörn M. Schattenberg; Peter R. Galle; Martin F. Sprinzl; Marcus-Alexander Wörns; Michael Nagel; Christian Labenz;

Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective Carlos Moctezuma-Velazquez; Graciela Castro-Narro; Pablo Simó; Elisabet Viayna; Susana Aceituno; Maria Soler; Aldo Torre;